Tingting Yuan Selected Research

Tingting Yuan Research Topics

Disease

6	Neoplasms (Cancer) 07/2023 - 02/2015
4	Osteoporosis 02/2024 - 07/2023
3	COVID-19 01/2023 - 01/2020
3	Infections 01/2021 - 10/2009
3	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2015
3	Hyperlipidemias (Hyperlipidemia) 04/2019 - 10/2018
3	Atherosclerosis 03/2019 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 04/2019
2	Fever (Fevers) 04/2023 - 03/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2015
2	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2020 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 01/2016
2	Breast Neoplasms (Breast Cancer) 02/2015 - 03/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2024
1	Communicable Diseases (Infectious Diseases) 10/2023
1	Bone Resorption 10/2023
1	Esophageal Neoplasms (Esophageal Cancer) 06/2023
1	Lymphoma (Lymphomas) 01/2023
1	Coronary Disease (Coronary Heart Disease) 12/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2022
1	Obesity 04/2021
1	Neurofibroma 01/2021
1	Pleomorphic Adenoma 12/2020
1	Glioma (Gliomas) 06/2020
1	Ischemic Stroke 04/2020
1	Cerebral Hemorrhage 04/2020
1	Infarction (Infarctions) 04/2020
1	Babesiosis (Piroplasmosis) 03/2020
1	Parasitemia 03/2020
1	Radiculopathy (Radiculopathy, Cervical) 01/2020
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 04/2019
1	Hemolysis 01/2019
1	Cysts 01/2019
1	Lung Injury 01/2019
1	Hypercholesterolemia 10/2018
1	Seizures (Absence Seizure) 10/2017
1	Hoarseness 10/2017
1	Werner Syndrome (Werner's Syndrome) 06/2015

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2023 - 07/2011
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2020
2	CholesterolIBA 03/2019 - 10/2018
2	Lipoproteins (Lipoprotein)IBA 03/2019 - 10/2018
2	ApolipoproteinsIBA 03/2019 - 10/2018
2	Apolipoproteins E (ApoE)IBA 03/2019 - 10/2018
2	LDL Receptors (LDL Receptor)IBA 03/2019 - 10/2018
2	CateninsIBA 02/2016 - 01/2016
2	Cadherins (E-Cadherin)IBA 01/2016 - 03/2013
1	SmokeIBA 02/2024
1	Virulence Factors (Pathogenicity Factors)IBA 10/2023
1	StrontiumIBA 10/2023
1	MetalsIBA 09/2023
1	ChlorophenolsIBA 07/2023
1	PhenolsIBA 07/2023
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 07/2023
1	phthalic acid (phthalate)IBA 07/2023
1	monobutyl phthalateIBA 07/2023
1	Ampicillin (Omnipen)FDA LinkGeneric 04/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	68Ga-FAPIIBA 12/2022
1	Gemcitabine FDA Link 08/2022
1	Small Interfering RNA (siRNA)IBA 08/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Endothelin-1 (Endothelin 1)IBA 04/2020
1	LDL CholesterolIBA 04/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2020
1	ChemokinesIBA 03/2020
1	Indicators and Reagents (Reagents)IBA 03/2020
1	RNA (Ribonucleic Acid)IBA 03/2020
1	CytokinesIBA 03/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 04/2019
1	oxidized low density lipoproteinIBA 04/2019
1	Therapeutic UsesIBA 04/2019
1	Scarlet Red (Sudan IV)IBA 03/2019
1	LipidsIBA 03/2019
1	AntioxidantsIBA 01/2019
1	puerarinIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	HLA-DQA1 antigen (HLA DQA1)IBA 01/2019
1	Long Noncoding RNAIBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 10/2016
1	Hormones (Hormone)IBA 02/2016
1	AcidsIBA 01/2016
1	HeterochromatinIBA 06/2015

Therapy/Procedure

5	Therapeutics 08/2022 - 01/2016
4	Drug Therapy (Chemotherapy) 08/2022 - 02/2015
3	Radiotherapy 01/2020 - 02/2015
1	Esophagectomy 06/2023
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Tracheostomy 01/2021
1	Laryngoscopes 01/2021
1	General Anesthesia 01/2021
1	Thrombolytic Therapy 04/2020